@article{oai:niigata-u.repo.nii.ac.jp:00019250, author = {水戸, 將郎 and 服部, 晃 and 花野, 政晴 and 布施, 一郎 and 帯刀, 亘 and 滝沢, 慎一郎 and 藤田, 俊夫 and 山添, 優 and 和泉, 徹 and 柴田, 昭 and 林, 純一 and 江口, 昭治 and 新潟GATS(Graft, Aspirin Ticlopidine Study)グループ}, issue = {7}, journal = {新潟医学会雑誌, 新潟医学会雑誌}, month = {Jul}, note = {Anticoagulant therapy (warfarin) with or without antiplatelet therapy was given to the patients who had encounterd aorto-coronary surgery for the prevention of restenosis. The antiplatelet therapy consisted of low-dose aspirin and ticlopidine. The dosage of the anti-plateket drugs were variable in individual patients since we tried to adjust the inhibition of the platelet aggregation by them to be apporpriate levels. The control range of platelet maximum aggregation rate (MAR) was 30-50% for ADP and 20-55% for collagen. Warfarin with this antiplatelet therapy was more effective than warfarin alone for the prevention of restenosis and the adverse effect was minimal.}, pages = {517--526}, title = {新しい抗血小板療法による冠動脈バイパス術後の閉塞防止の研究 : 第一報 : 微量アスピリンとチクロピジン併用による血小板機能抑制}, volume = {108}, year = {1994} }